BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17592252)

  • 41. Foxp3 regulates megakaryopoiesis and platelet function.
    Bernard JJ; Seweryniak KE; Koniski AD; Spinelli SL; Blumberg N; Francis CW; Taubman MB; Palis J; Phipps RP
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1874-82. PubMed ID: 19661482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetic mechanisms of regulation of Foxp3 expression.
    Lal G; Bromberg JS
    Blood; 2009 Oct; 114(18):3727-35. PubMed ID: 19641188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular orchestration of differentiation and function of regulatory T cells.
    Lu LF; Rudensky A
    Genes Dev; 2009 Jun; 23(11):1270-82. PubMed ID: 19487568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3.
    Samanta A; Li B; Song X; Bembas K; Zhang G; Katsumata M; Saouaf SJ; Wang Q; Hancock WW; Shen Y; Greene MI
    Proc Natl Acad Sci U S A; 2008 Sep; 105(37):14023-7. PubMed ID: 18779564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FOXP3 and its partners: structural and biochemical insights into the regulation of FOXP3 activity.
    Zhou Z; Song X; Li B; Greene MI
    Immunol Res; 2008; 42(1-3):19-28. PubMed ID: 18626575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Special regulatory T-cell review: FOXP3 biochemistry in regulatory T cells--how diverse signals regulate suppression.
    Li B; Greene MI
    Immunology; 2008 Jan; 123(1):17-9. PubMed ID: 18154614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcriptional regulation of Foxp3 in regulatory T cells.
    Haiqi H; Yong Z; Yi L
    Immunobiology; 2011 Jun; 216(6):678-85. PubMed ID: 21122941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression.
    Li B; Samanta A; Song X; Iacono KT; Bembas K; Tao R; Basu S; Riley JL; Hancock WW; Shen Y; Saouaf SJ; Greene MI
    Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4571-6. PubMed ID: 17360565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency.
    Bettini ML; Pan F; Bettini M; Finkelstein D; Rehg JE; Floess S; Bell BD; Ziegler SF; Huehn J; Pardoll DM; Vignali DA
    Immunity; 2012 May; 36(5):717-30. PubMed ID: 22579476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different molecular complexes that mediate transcriptional induction and repression by FoxP3.
    Kwon HK; Chen HM; Mathis D; Benoist C
    Nat Immunol; 2017 Nov; 18(11):1238-1248. PubMed ID: 28892470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FOXP3 actively represses transcription by recruiting the HAT/HDAC complex.
    Li B; Greene MI
    Cell Cycle; 2007 Jun; 6(12):1432-6. PubMed ID: 17592252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune regulation by histone deacetylases: a focus on the alteration of FOXP3 activity.
    Zhang H; Xiao Y; Zhu Z; Li B; Greene MI
    Immunol Cell Biol; 2012 Jan; 90(1):95-100. PubMed ID: 22124370
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.